What is Mosaic Immunoengineering Inc?
, a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. It engages in pursuing new product candidates and platforms to build a new pipeline based on immunotherapies. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 2.27M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.